Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma

NICE U-turn sees Celgene's Imnovid backed for multiple myeloma Imnovid has been given the nod for the treatment of people with relapsed or refractory multiple myeloma who have undergone three previous treatments, including Celgene's Revlimid (lenalidomide) and Takeda's

Optimising Outcomes

It became critical to ensure that patients were successfully treated with REVLIMID until disease progression. ... longer-term focus on maintaining patients on REVLIMID until disease progression through better side-effect management.

NICE set to knock-back Amgen's myeloma treatment Kyprolis

NICE set to knock-back Amgen's myeloma treatment Kyprolis NICE's draft guidance is part of its assessment for NHS use of Kyprolis (carflizomib) in combination with Celgene's Revlimid (lenalidomide) and dexamethasone to treat adults who have received at ... NICE's draft guidance on its use in combination with

Celgene bolsters blood cancer portfolio with $600m EngMab buy

Celgene bolsters blood cancer portfolio with $600m EngMab buy bb2121 started phase I testing earlier this year. EngMab consolidates Celgene's position as the top company in the multiple myeloma market at the moment, thanks to blockbuster drugs Revlimid (lenalidomide)

Celgene disappointed as Revlimid fails lymphoma trial

Celgene disappointed as Revlimid fails lymphoma trial PFS alone is not considered compelling as Revlimid carries a risk of serious side effects, including thrombosis. ... It is important to note that Celgene is not abandoning Revlimid as a DLBCL therapy just yet.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics